Avalon GloboCare Corp. (ALBT) - Net Assets
Based on the latest financial reports, Avalon GloboCare Corp. (ALBT) has net assets worth $9.23 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($23.40 Million) and total liabilities ($14.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Avalon GloboCare Corp. debt and liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $9.23 Million |
| % of Total Assets | 39.44% |
| Annual Growth Rate | N/A |
| 5-Year Change | 199.25% |
| 10-Year Change | 160.28% |
| Growth Volatility | 92.88 |
Avalon GloboCare Corp. - Net Assets Trend (2015–2025)
This chart illustrates how Avalon GloboCare Corp.'s net assets have evolved over time, based on quarterly financial data. Also explore total assets of Avalon GloboCare Corp. for the complete picture of this company's asset base.
Annual Net Assets for Avalon GloboCare Corp. (2015–2025)
The table below shows the annual net assets of Avalon GloboCare Corp. from 2015 to 2025. For live valuation and market cap data, see market cap of Avalon GloboCare Corp..
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $9.23 Million | +29.95% |
| 2024-12-31 | $7.10 Million | -3.61% |
| 2023-12-31 | $7.37 Million | -33.97% |
| 2022-12-31 | $11.16 Million | +261.79% |
| 2021-12-31 | $3.08 Million | -25.08% |
| 2020-12-31 | $4.12 Million | -7.80% |
| 2019-12-31 | $4.47 Million | -60.32% |
| 2018-12-31 | $11.25 Million | +53.98% |
| 2017-12-31 | $7.31 Million | +106.10% |
| 2016-12-31 | $3.55 Million | +65697.32% |
| 2015-12-31 | $-5.41K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Avalon GloboCare Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 10593060100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $486.00 | 0.01% |
| Other Comprehensive Income | $-234.82K | -2.54% |
| Other Components | $115.40 Million | 1250.24% |
| Total Equity | $9.23 Million | 100.00% |
Avalon GloboCare Corp. Competitors by Market Cap
The table below lists competitors of Avalon GloboCare Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Health and Plant Protein Group Ltd
AU:HPP
|
$3.37 Million |
|
Ucommune International Ltd
NASDAQ:UK
|
$3.38 Million |
|
OZZ Resources Ltd
AU:OZZ
|
$3.38 Million |
|
KWESST Micro Systems Inc. Common Stock
NASDAQ:KWE
|
$3.38 Million |
|
Inomin Mines Inc
V:MINE
|
$3.37 Million |
|
AFRICAN PIONEER PLC O.N.
F:9TI
|
$3.37 Million |
|
Euro Kapital Yatirim Ortakligi AS
IS:EUKYO
|
$3.36 Million |
|
Marula Mining PLC
F:48U0
|
$3.36 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Avalon GloboCare Corp.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 7,102,623 to 9,230,108, a change of 2,127,485 (30.0%).
- Net loss of 17,518,873 reduced equity.
- New share issuances of 775,500 increased equity.
- Other comprehensive income decreased equity by 9,402.
- Other factors increased equity by 18,880,260.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-17.52 Million | -189.8% |
| Share Issuances | $775.50K | +8.4% |
| Other Comprehensive Income | $-9.40K | -0.1% |
| Other Changes | $18.88 Million | +204.55% |
| Total Change | $- | 29.95% |
Book Value vs Market Value Analysis
This analysis compares Avalon GloboCare Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.15x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $-0.03 | $0.42 | x |
| 2016-12-31 | $0.69 | $0.42 | x |
| 2017-12-31 | $1.21 | $0.42 | x |
| 2018-12-31 | $1.68 | $0.42 | x |
| 2019-12-31 | $0.59 | $0.42 | x |
| 2020-12-31 | $0.52 | $0.42 | x |
| 2021-12-31 | $0.36 | $0.42 | x |
| 2022-12-31 | $1.20 | $0.42 | x |
| 2023-12-31 | $0.70 | $0.42 | x |
| 2024-12-31 | $7.58 | $0.42 | x |
| 2025-12-31 | $2.87 | $0.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Avalon GloboCare Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -189.80%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 2.54x
- Recent ROE (-189.80%) is below the historical average (-158.96%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-30.47K |
| 2016 | 1.57% | 9.02% | 0.17x | 1.05x | $-299.04K |
| 2017 | -43.88% | -321.50% | 0.09x | 1.60x | $-4.25 Million |
| 2018 | -64.16% | -497.61% | 0.12x | 1.11x | $-8.99 Million |
| 2019 | -404.70% | -1168.60% | 0.15x | 2.35x | $-18.52 Million |
| 2020 | -307.98% | -920.29% | 0.13x | 2.52x | $-13.09 Million |
| 2021 | -294.73% | -653.54% | 0.14x | 3.32x | $-9.40 Million |
| 2022 | -106.92% | -992.44% | 0.06x | 1.77x | $-13.05 Million |
| 2023 | -226.73% | -1330.51% | 0.06x | 2.79x | $-17.44 Million |
| 2024 | -111.27% | -592.72% | 0.06x | 2.95x | $-8.61 Million |
| 2025 | -189.80% | 0.00% | 0.00x | 2.54x | $-18.44 Million |
Industry Comparison
This section compares Avalon GloboCare Corp.'s net assets metrics with peer companies in the Real Estate Services industry.
Industry Context
- Industry: Real Estate Services
- Average net assets among peers: $7,734,874,830
- Average return on equity (ROE) among peers: -185.21%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Avalon GloboCare Corp. (ALBT) | $9.23 Million | 0.00% | 1.54x | $3.37 Million |
| reAlpha Tech Corp. Common Stock (AIRE) | $1.57 Million | -1660.19% | 6.65x | $42.58 Million |
| American Realty Investors Inc (ARL) | $816.51 Million | 0.49% | 0.25x | $235.34 Million |
| Altisource Portfolio Solutions SA (ASPS) | $86.35 Million | 30.08% | 0.40x | $76.47 Million |
| Ke Holdings Inc (BEKE) | $66.79 Billion | 4.16% | 0.56x | $18.34 Billion |
| CBRE Group Inc Class A (CBRE) | $784.29 Million | 4.25% | 5.43x | $42.20 Billion |
| Comstock Holding Companies Inc (CHCI) | $6.63 Million | -68.11% | 4.29x | $158.95 Million |
| Compass Inc (COMP) | $-681.60 Million | 0.00% | 0.00x | $5.49 Billion |
| CoStar Group Inc (CSGP) | $359.01 Million | 5.21% | 0.13x | $14.72 Billion |
| Cushman & Wakefield plc (CWK) | $1.45 Billion | 17.26% | 4.45x | $2.99 Billion |
About Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in… Read more